International Journal of Drug Delivery Technology
Volume 14, Issue 1

Analytical Review on Newly Approved Antidiabetic and Antihypertensive Drugs

K Pravalika1*, Subhashini V2

1Department of Pharmaceutical Analysis, Marri Laxman Reddy Institute of Pharmacy, Hyderabad, Telangana, India.

2Department of Pharmacology, Vels Institute of Science, Technology & Advanced Studies, Pallavaram, Chennai, Tamil Nadu, India.

Received: 23rd January, 2024; Revised: 28th February, 2024; Accepted: 07th March, 2024; Available Online: 25th March, 2024

ABSTRACT

Diabetes and hypertension are the principal causes of death all over the world. Both diabetes and hypertension coexist frequently. Managing both is a multi-faced task requiring extensive care. Therapeutic intervention optimization and ensuring patient safety are the results of assessing medications in biological samples. The development of an analytical technique specific to the measurement of a medicinal chemical in a certain matrix requires careful consideration of the various equipment options and an understanding of their relative capabilities with regard to selectivity, sensitivity, usability, speed of investigation, etc. This article aimed to systematically analyze many popular quantitative analytical techniques for measuring some newly approved antidiabetic and antihypertensive drugs in pharmaceutical planning. Several chromatographic techniques have been employed for quantitative research into these pharmaceuticals. Rapid, accurate, cost-effective, and straightforward drug analysis methods are now essential for developing and using new technologies.

Keywords: Analytical methods, Diabetes, Hypertension, Antidiabetic drugs, Antihypertensive drugs, FDA-approval. International Journal of Drug Delivery Technology (2024); DOI: 10.25258/ijddt.14.1.74

How to cite this article: Pravalika K, Subhashini V. Analytical Review on Newly Approved Antidiabetic and Antihypertensive Drugs. International Journal of Drug Delivery Technology. 2024;14(1):537-544.

REFERENCES

  1. World Health Organization (WHO). In: Yearbook of the United Nations 1984. United Nations; (1984).
  2. Beevers G, Lip GY, O’Brien ABC of hypertension: The pathophysiology of hypertension.( 2001)
  3. Booz GW. Left ventricular physiology and pathophysiology in hypertension. In: Comprehensive Elsevier. (2007). 113–21.
  4. Mukhtar Y, Galalain A, Yunusa A modern overview on diabetes mellitus: a chronic endocrine disorder. European Journal of Biology. (2020)
  5. Kumar R, Saha P, Kumar Y, Sahana S, Dubey A, Prakash O. A Review on Diabetes Mellitus: Type1 & World Journal of Pharmacy and Pharmaceutical Sciences. (2020)
  6. Arneth B, Arneth R, Shams Metabolomics of type 1 and type 2 diabetes. International journal of molecular sciences. (2019) May 18;20(10):2467.
  7. Diabetes statistics 2023 [Internet]. Available from: https:// singlecare.com/blog/ news/diabetes-statistics/. (2023)
  8. Eizirik DL, Szymczak F, Alvelos MI, Martin From pancreatic β-cell gene networks to novel therapies for type 1 diabetes.(2021) Sep 1;70(9):1915-25.
  9. Liu W, Huang X, Zhang X, Cai X, Han X, Zhou X, Chen L, Zhang R, Gong S, Wang Y, Ji L. Urinary C-peptide creatinine ratio as a non-invasive tool for identifying latent autoimmune diabetes in adults (LADA). Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy. (2019) Dec 2:2531-7.
  10. Banday MZ, Sameer AS, Nissar Pathophysiology of diabetes: An overview. Avicenna J Med [In. 2020;10(4):174–88. Available from: http://dx.doi.org/10.4103/ajm.ajm5320. (2020)
  11. Pratima NA, Gadikar Lupine Publishers. Archives of Organic and Inorganic Chemical Sciences [Internet]. 2018 [cited 2023 Jul 3];1(1):001–9. Available from: https:// lupinepublishers. com/chemistry-journal/fulltext/liquid- chromatography-massspectrometry-and-its-applications-a-brief- review.ID.000103.php. (2018)
  12. Primer Basics of LC/MS [Internet]. Agilent.com. [cited 2023 Jul 3]. Available from: https://www.agilent.com/cs/library/ support/documents/a05296.pdf. (2023)
  13. Kumar PR, Dinesh SR, R. LCMS- A REVIEW AND A RECENT UPDATE. Re view Article ISSN [Internet]. 5(5):377– 91. Available from: https://storage.googleapis.com/ journaluploads/wjpps/article_issue/1461928421.pdf
  14. Zimmer D. Introduction to quantitative liquid chromatography tandem mass spectrometry (LC-MS-MS). Chromatographia [Internet]. 2003;57(S1):S325–32. Available from: http://dx.doi. org/10.1007/bf02492124. (2003).
  15. Vuckovic D, Zhang X, Cudjoe E, Pawliszyn J. Solid-phase microextraction in bioanalysis: New devices and directions. Journal of Chromatography A. 2010 Jun 18;1217(25):4041-60. (2010)
  16. Zhang C, Xing H, Yang L, Fei P, Liu Development trend and prospect of solid phase extraction technology. Chinese Journal of Chemical Engineering. (2022) Feb 1;42:245-55.
  17. Badawy ME, El-Nouby MA, Kimani PK, Lim LW, Rabea A review of the modern principles and applications of solid-phase extraction techniques in chromatographic analysis. Analytical Sciences. (2022) Dec;38(12):1457-87.
  18. Kulyk DS, Sahraeian T, Lee S, Badu-Tawiah Microsampling with a solid-phase extraction cartridge: storage and online mass spectrometry analysis. Analytical chemistry. (2021) Sep 30;93(40):13632-40.
  19. Bokhary A, Leitch M, Liao BQ. Liquid–liquid extraction technology for resource recovery: Applications, potential, and perspectives. Journal of Water Process (2021) Apr 1;40:101762.
  20. Li L, Liu F, Kong XX, et al. Bioanalysis of Drugs using mass spectrometry. Chinese Chem Lett. (2002); 13: 349-350.
  21. Sagdullaev SS, Sadikov, Shakirov TT, et al. Liquid-liquid extraction technology for production of the antiarrhythmic drug aclezin from the above-ground part of Aconitum leucostomum. Pharm Chem. J.( 2000); 34: 310-312
  22. Kang L, Weng N, Jian LC–MS bioanalysis of intact proteins Short Title is missing IJDDT, Volume 14 Issue 1, January - March 2024 Page 7 and peptides. Biomedical chromatography. (2020) Jan;34(1):e4633.
  23. Hofbauer S, Salamatipour A, Blair IA, Mesaros C. Sample Preparation for LC‐MS Bioanalysis of Sample Preparation in LC‐MS Bioanalysis. (2019) Feb 25:275-83.
  24. Yuan Sample preparation for LC‐MS bioanalysis of peptides. Sample Preparation in LC‐MS Bioanalysis. (2019) Feb 25:284- 303.
  25. Dethy JM, Ackermann BL, Delatour C, et al. Demonstration of Direct Bioanalysis of Drugs in Plasma Using Nanoelectrospray Infusion from a Silicon Chip Coupled with Tandem Mass Spectrometry. Anal Chem. (2003); 75: 805-811.
  26. Sadaphal P, Dhamak K. Review article on high-Performance Liquid Chromatography (HPLC) method development and validation. Int J Pharm Sci Rev Res [Internet]. (2022); 23–9.
  27. Sankar PR, Geethika AS, Rachana G, Babu PS, Bhargavi J. Bioanalytical method validation: A comprehensive review. Int.
  28. Pharm. Sci. Rev. Res. (2019);9:50-8.
  29. Raposo F, Ibelli-Bianco Performance parameters for analytical method validation: Controversies and discrepancies among numerous guidelines. TrAC Trends in Analytical Chemistry. (2020) Aug 1;129:115913.
  30. González AG, Herrador MÁ. A practical guide to analytical method validation, including measurement uncertainty and accuracy profiles. TrAC Trends in Analytical Chemistry. 2007 Mar 1;26(3):227-38.
  31. Rao TN. Validation of analytical methods. Calibration and validation of analytical methods—A sampling of current approaches. (2018) Apr 25:131-41.
  32. Ravisankar P, Navya CN, Pravallika D, Sri DN. A review on step-by-step analytical method IOSR J Pharm. (2015) Oct;5(10):7-19.
  33. Thakur D, Dubey NP, Singh A Review on Spike and Recovery Method in Analytical Method Development and Validation. Critical Reviews in Analytical Chemistry. (2022) Nov 25:1-9.
  34. Haid M, Muschet C, Wahl S, Römisch-Margl W, Prehn C, Möller G, Adamski Long-term stability of human plasma metabolites during storage at− 80 C. Journal of proteome research. 2018 Jan 5;17(1):203-11.
  35. Wang J, Nowatzke W, Ma M. Current industrial practices and regulatory requirements to assess analyte and reagent stability using ligand-binding assays. Bioanalysis. (2015) Jun;7(11):1371-
  36. Ozkan SA. Analytical method validation: the importance for pharmaceutical analysis. Pharm Sci. (2018) Jan 1;24(1):1-2.
  37. Bansal S, DeStefano A. Key elements of bioanalytical method validation for small molecules. The AAPS journal. (2007) Mar;9:E109-14.
  38. Peters FT, Drummer OH, Musshoff F. Validation of new methods. Forensic science international. (2007) Jan 17;165(2-3):216-24.
  39. Nishant T, Kumar A, Sathish Kumar D, Vijaya Shanti B. Development and validation of analytical methods for J. Anal. Bioanal. Tech. (2011) Dec 6;2(127):1-5.
  40. Lavanya G, Sunil M, Eswarudu MM, Eswaraiah MC, Harisudha K, Spandana BN. Analytical method validation: an updated review. International Journal of Pharmaceutical Sciences and Research. (2013) Apr 1;4(4):1280.
  41. Lal B, Kapoor D, Jaimini M. A review on analytical method validation and its regulatory perspectives. Journal of Drug Delivery and Therapeutics. (2019) Mar 14;9(2):501-6.
  42. Geetha G, Raju KN, Kumar BV, Raja MG. Analytical method validation: an updated. Review. Int. J. Pharm. Biol. Sci. (2012);1:64-71.
  43. Chikanbanjar N, Semwal N, Jyakhwa U. A review article on analytical method validation. J. Pharm. Innov. (2020);1:48-58.
  44. Sahoo CK, Sudhakar M, Ramana DV, Satyanarayana K, Panda KC. Validation of analytical procedures-A Asian Journal of Pharmaceutical Analysis. (2018);8(2):109-16.
  45. Araujo P. Key aspects of analytical method validation and linearity evaluation. Journal of chromatography B. (2009) Aug 1;877(23):2224-34.
  46. Beskan U, Yildirim ST, Yapar EA. An overview of analytical method validation. J. Pharm. Res. (2020);5:47-52.
  47. Nguyen DT, Guillarme D, Rudaz S, Veuthey JL. Fast analysis in liquid chromatography using small particle size and high Journal of separation science. (2006) Aug;29(12):1836-Introduction to new chromatography technique - UPLC . PharmaTutor. Available from: https://www.pharmatutor. org/articles/new- chromatographictechnique-uplc-ultra- performance-liquid-chromatography. (2011)
  48. Amara Babu NL, Koganti K, Palakeeti B, Srinivas KS, Rao Development of an efficient stability‐indicating LC–MS/ MS method for the analysis of selexipag and characterization of its degradation products. Biomedical Chromatography. (2021) Oct;35(10):e5178.
  49. Shah P, Hadiyal S, Dhaduk Stability Indicating LC-MS/MS Method and Validation of Selexipag Impurities and Identification of its Force Degradation Products. (2021)
  50. Rao KP, babu NL, Koganti K, Palakeeti B, Srinivas Related substances method development and validation of an LCMS/MS method for quantification of selexipag and its related impurities in rat plasma and its application to pharmacokinetic studies. SN Applied Sciences.( 2021) Mar;3:1-2.
  51. Kumar M, Chandra U, Garg A, Gupta P. Development and Validation of In-vitro dissolution test using RP-HPLC Analysis for simultaneous estimation of Azelnidipine and Telmisartan in a Fixed-dose Combination. Research Journal of Pharmacy and Technology. (2022);15(5):1967-72.
  52. Suthar P, Mashru Advanced UV Spectrophotometric Method Development and Validation for Simultaneous Estimation of Azelnidipine and Telmisartan in Pharmaceutical Dosage Form: Advanced UV Spectrophotometric Method Development and Validation. Indian Journal of Pharmacy & Drugs Studies. (2022) Dec 17:128-34.
  53. Bhosale A, Pingle Bioanalytical RP-HPLC method development and validation for estimation of azelnidipine and Olmesartan medoxomil in human plasma. Journal of MedicalPharmaceutical and allied sign. (2022);11(5):5235-9.
  54. Padmalatha K, Durga DV, Jagadeeswari N. A Novel Study on rp-Hplc Method Development and Validation for Estimation of Netarsudil and Latanoprost in Api and Pharmaceutical Dosage Form. World J. Pharm. Pharm. Sci.( 2021) Jul 2;10:1624-33.
  55. Sharanya PS, Rani Development and Validation of Stability Indicating Analytical Method for the Simultaneous Estimation of Netarsudil and Latanoprost by RP-HPLC: https://doi. org/10.54037/WJPS. 2022.100111. World Journal of Pharmaceutical Sciences. (2022) Jan 2:104-12.
  56. Saravanan K, Dhanabalan K, Shanmugam GK, Ramanathan S. A Stability-indicating UPLC-TUV method for the simultaneous estimation of Netarsudil and Latanoprost in bulk Short Title is missing IJDDT, Volume 14 Issue 1, January - March 2024 Page 8 drug and ophthalmic preparations. Journal of Pharmaceutical Chemistry. (2022) Jul 20;8(Supplement).
  57. Arora A, Nagaich U, Pal D, Chaurasia S, Jain N. Development and Validation of UV-Spectrophotometric Method Towards Determination of Ripasudil Hydrochloride Hydrate in Pure and Ophthalmic Journal of Applied Spectroscopy. (2023) Mar;90(1):206-12.
  58. Hui W, Sun L, Zhang H, Zou L, Zou Q, Ouyang Quantitative analysis of ripasudil hydrochloride hydrate and its impurities by reversed‐phase high‐performance liquid chromatography after precolumn derivatization: Identification of four impurities. Journal of Separation Science. (2016) Sep;39(17):3302-10.
  59. Kocak OF, Albayrak M, Yaman ME, Atila A, Kadioglu Y, Araz Determination and pharmacokinetic study of riociguat by UPLC-MS/MS in human plasma. Journal of Chromatography (2022) Nov 1;1210:123454.
  60. Hložek T, Štícha M, Bursová M, Jelínek I, Tůma P, Čabala Sensitive CE‐MS method for monitoring of riociguat and desmethylriociguat levels in human serum. Electrophoresis. (2020) Oct;41(18-19):1564-7.
  61. Todkar PR, Dichwalkar S, Hamrapurkar P. Stability indicating HPLC method for determination of Riociguat in bulk and pharmaceutical dosage form. ISCB Int. (2020).
  62. Solanki RV, Patel RB, Patel RK, Patel BM. Development and Validation of Fast and Robust Stability Indicating RP-HPLC Method for Simultaneous Estimation of Azilsartan Medoxomil and Cilnidipine in Pharmaceutical Dosage Form. International Journal of Pharmaceutical Investigation. ( 2022) Jul 1;12(3).
  63. Solanki DP, Solanki KH, Desai JV, Shah DA, Chhalotiya UK. HPTLC-Densitometric Estimation of Antihypertensive Drug Combination Azilsartan Medoxomil and Cilnidipine in Combined Dosage Form. Analytical Chemistry Letters. (2023) Jan 2;13(1):82-94.
  64. Shah JP, Akabari Development and Validation of Analytical Method for Estimation of Azilsartan Medoxomil and Chlorthalidone in Api And Pharmaceutical Dosage Form. International Journal of Pharmaceutical Research and Applications. 2022;7(3): 1251-1262
  65. Dhaware A, Dhudhal B. Analytical Method Development and Validation for Assay of Fimasartan Potassium Trihydrate and Chlorthalidone in Table Dosage Form by using RP-HPLC. International Research Journal of Pharmacy and Medical Sciences. (2022);5(4): 24-30.
  66. Sruthi A, Uttam Prasad Stability indicating method development and validation of fimasartan by reverse phase high performance liquid chromatography in bulk and pharmaceutical dosage form. Asian J Pharm Clin Res. (2021);14(2):138-46.
  67. Sojitra RG, Chotaliya UJ. Analytical method development and validation for simultaneous estimation of Fimasartan Potassium Trihydrate and Cilnidipine in synthetic mixture by HPLC for the treatment of hypertension stage-II. Future Journal of Pharmaceutical Sciences. (2021) Dec;7:1-7.
  68. Chohan MS, Attimarad M, Venugopala KN, Nair AB, Sreeharsha N, Molina EI, Kotnal RB, Shafi S, David M, Shinu P, Altaysan AI. Sensitivity Enhanced Ecofriendly UV Spectrophotometric Methods for Quality Control of Telmisartan and Benidipine Formulations: Comparison of Whiteness and Greenness with HPLC Methods. International Journal of Environmental Research and Public Health. (2022) Jun 14;19(12):7260.
  69. Pattanik SK, Pradhan KK. Development and Validation of Stability Indicating Hptlc Method for Simultaneous Estimation of Telmisartan and Gallic Acid as Per Ich Q1a (R2). Available at SSRN 4233902. (2022) Sep 30.
  70. Saiyed SA, Jadeja P, Mashru R. Development and Validation of Extractive Spectrophotometric Methods for the Estimation of Telmisartan by Using Smartphone Application. Journal of Drug Delivery and (2022) Jun 17;12(3-S):178-90.
  71. Ilayaraja P, Manivannan M, Parthiban P. A Selective and Sensitive Method for the Determination of Sulfonate Ester Impurities in Saxagliptin Drug Substance by HPLC. Journal of Pharmaceutical Negative Results.( 2022) Dec 31:2028-32.
  72. Gurrala S, Shiva RA, Subrahmanyam CV, Anumolu DP, Naraparaju S, Nizampet H. Response Surface Methodology in Spectrophotometric Estimation of Saxagliptin, Derivatization with MBTH and Ninhydrin. Turkish Journal of Pharmaceutical Sciences. (2022) Feb;19(1):9.
  73. Kurian A, Rekha TN, Bhagyalakshmi C, Ahmed SS, Pasha YT, Ramesh B, Majumder M. Simple high performance liquid chromatography method for simultaneous quantification of saxagliptin and dapagliflozin in rat (2022);59(7):52-59.
  74. Sunkara B, Gampa TR, Markanti M, Midthapally RK. Stability indicating method development and validation for simultaneous estimation and quantification of Ertugliflozin and Metformin in bulk and tablet dosage form. Future Journal of Pharmaceutical Sciences.( 2021) Dec;7(1):1-0.
  75. Addanki Novel stability-indicating RP-UPLC method for simultaneous estimation of sitagliptin and ertugliflozin in bulk and pharmaceutical formulations. Future Journal of Pharmaceutical Sciences. (2021) Dec;7(1):1-0.
  76. Khoja SS, Patel Development and validation of new analytical LCMS/MS method for the estimation of antidiabetic drugs Ertugliflozin and sitagliptin in combined pharmaceutical dosage form. J. Pharmaceut. Res. Int.. (2021);33(30A):194-204.
  77. Manasa M, Aanandhi Stability indicating method development and validation of semaglutide by RP-HPLC in pharmaceutical substance and pharmaceutical product. Research Journal Of Pharmacy And Technology. ( 2021);14(3):1385-9.
  78. Lee TS, Park EJ, Choi M, Oh HS, An Y, Kim T, Kim TH, Shin BS, Shin S. Novel LC-MS/MS analysis of the GLP-1 analog semaglutide with its application to pharmacokinetics and brain distribution studies in Journal of Chromatography B. (2023) Apr 15;1221:123688.
  79. Penmetsa SH, Sundararajan R. Method development and validation of semaglutide by UV spectrophotometric method in bulk and pharmaceutical dosage form. International Journal of Research and Analytical Reviews.( 2019) Jun;6(2):394-402.
  80. Kenfack F, Nsagha DS, Assob JC. Abnormal liver function test in patients with diabetes and hypertension on treatment at the Laquintinie and Douala General Hospitals. Journal of Public Health and Epidemiology. (2022) Nov 30;14(4):160-5.